Atrial fibrillation and hypertension

MS Dzeshka, A Shantsila, E Shantsila, GYH Lip - Hypertension, 2017 - Am Heart Assoc
Pathophysiologically lower BPs results in less strain on the LV, and, thus, more aggressive
BP control may have benefits in terms of LV hypertrophy, myocardial fibrosis, diastolic …

Hypertension and atrial fibrillation: an intimate association of epidemiology, pathophysiology, and outcomes

MS Dzeshka, F Shahid, A Shantsila… - American Journal of …, 2017 - academic.oup.com
Atrial fibrillation (AF) is the most prevalent sustained arrhythmia found in clinical practice. AF
rarely exists as a single entity but rather as part of a diverse clinical spectrum of …

[PDF][PDF] Patients with atrial fibrillation undergoing percutaneous coronary intervention

MS Dzeshka, RA Brown, GYH Lip - Polskie Archiwum Medycyny …, 2015 - core.ac.uk
Atrial fibrillation (AF) and coronary artery disease (CAD) often coexist. Both conditions confer
an increased risk of acute thrombotic complications. However, the pathogenesis of thrombus …

Direct oral anticoagulant reversal: how, when and issues faced

MS Dzeshka, D Pastori, GYH Lip - Expert Review of Hematology, 2017 - Taylor & Francis
Introduction: The number of atrial fibrillation (AF) patients requiring thrombo-prophylaxis with
oral anticoagulation is greatly increasing. The introduction of non-vitamin K oral …

Antiplatelet and antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting.

MS Dzeshka, RA Brown, D Capodanno… - Interventional …, 2017 - europepmc.org
Stroke prevention is the main priority in the management cascade of atrial fibrillation. Most
patients require long-term oral anticoagulation (OAC) and may require percutaneous …

[HTML][HTML] Cardiac radiosurgery for the treatment of atrial fibrillation

N Bhatt, T Fogarty, P Maguire - World Journal of Cardiovascular Diseases, 2016 - scirp.org
An estimated 4 million Americans currently have atrial fibrillation (AF), the most common
form of cardiac arrhythmia. The annual growth rate of AF is approximately 9.2% and …

Edoxaban for reducing the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation

MS Dzeshka, GYH Lip - Expert Opinion on Pharmacotherapy, 2015 - Taylor & Francis
Introduction: Oral anticoagulation is central to the management of patients with atrial
fibrillation (AF) and at least one additional stroke risk factor. For decades, the vitamin K …

Editorial commentary: Reversal agents in the era of non-vitamin k antagonists oral anticoagulants: Necessity or psychological crutch?

MS Dzeshka, GYH Lip - Trends in cardiovascular …, 2020 - pubmed.ncbi.nlm.nih.gov
Editorial commentary: Reversal agents in the era of non-vitamin k antagonists oral
anticoagulants: Necessity or psychological crutch? Editorial commentary: Reversal agents in the …

[HTML][HTML] Микробиологическая эффективность комбинаций антибиотиков в отношении инвазивных штаммов klebsiella pneumoniae

ЕВ Тимошкова, ДВ Тапальский… - Журнал …, 2021 - cyberleninka.ru
Введение. Комбинированная антибиотикотерапия-основной способ лечения
инфекций, вызванных антибиотикорезистентными бактериями. Цель исследования …

КЛИНИЧЕСКАЯ ХАРАКТЕРИСТИКА ПАЦИЕНТОВ С ФИБРИЛЛЯЦИЕЙ ПРЕДСЕРДИЙ И НИЗКОЙ ПРИВЕРЖЕННОСТЬЮ К ЛЕЧЕНИЮ

МС Дешко, СЛ Бойко, ВА Снежицкий… - Актуальные проблемы …, 2021 - elibrary.ru
Актуальность. Высокая распространенность фибрилляции предсердий (ФП) в
популяции и риск осложнений, связанный с данным нарушением ритма, обуславливает …